GB925538A - Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives - Google Patents

Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives

Info

Publication number
GB925538A
GB925538A GB793161A GB793161A GB925538A GB 925538 A GB925538 A GB 925538A GB 793161 A GB793161 A GB 793161A GB 793161 A GB793161 A GB 793161A GB 925538 A GB925538 A GB 925538A
Authority
GB
United Kingdom
Prior art keywords
compounds
give
benzyloxyethyl
piperazine
aminoalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB793161A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12966A external-priority patent/US3192204A/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of GB925538A publication Critical patent/GB925538A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/90Xanthenes with hydrocarbon radicals, substituted by amino radicals, directly attached in position 9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

The invention comprises trifluoromethyl xanthenes and thiaxanthenes of the formula <FORM:0925538/IV(a)/1> and their salts, wherein Y = S or O, R1 = H or OH when R2 is hydrogen, R1 and R2 taken together form a single bond, R3 = H or CH3 and Z is a basic nitrogen containing radical of not more than 15 carbon atoms such as dialkylamino, pyrrolidino, piperidino and 4-alkyl-, hydroxyalkyl-, acetoxyalkyl-, carbamoyloxyalkyl-, dialkylcarbamoyloxyalkyl-, hydroxyethoxyethyl-, hydroxyethoxyethoxyethyl- and benzoyloxyalkyl-substituted piperazino groups. The trifluoromethyl group is preferably in the 2-position of the xanthene or thiaxanthene ring. The compounds are made by reacting a trifluoromethylxanthenone or thiaxanthenone with an aminoalkyl magnesium halide Z,CH2,CH(R3),CH2,Mg.Halogen, dehydrating the resulting 10-aminoalkyl-10- hydroxytrifluoromethylxanthene or thiaxanthene by treatment with acid such as hydrochloric or sulphuric acid, or with an acid anhydride such as acetic anhydride to give the corresponding aminoalkylidene compounds of the invention, and, if desired, reducing, e.g. by catalytic hydrogenation to give the aminoalkyl compounds. Benzyloxyalkylpiperazinyl compounds prepared by the above procedures may be treated with mineral acid to give a hydroxyalkylpiperazinyl derivative which may in turn be acylated to give the corresponding acetoxyalkyl and dialkylcarbamoyloxyalkyl compounds or may be chlorinated to give a chloroalkylpiperazinyl compound, e.g. a chloroethylpiperazinyl compound from which hydroxyethoxyethyl or hydroxyethoxyethoxyethyl compounds are made by treatment with an appropriate glycol. The carbamoyloxalkyl-piperazino compounds are made by converting the hydroxyalkyl piperazino compounds to the phenyl carbonate salt and treating with ammonia. The products are used pharmaceutically suitably in the form of their salts with organic and inorganic acids (many specified). 1-Benzyloxyethyl- 4-chloropropylpiperazine is made by converting benzyloxyethanol into its p-toluenesulphonate, reacting with N-ethoxycarbonyl-piperazine to give 1-benzyloxyethyl-4-ethoxycarbonyl-piperazine, hydrolysing and decarboxylating to N-benzyloxyethylpiperazine, reacting with 3-bromopropanol to give 1-benzyloxyethyl-4-(3-hydroxypropyl)-piperazine and chlorinating with thionyl chloride. Specification 925,539 is referred to.
GB793161A 1960-03-07 1961-03-03 Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives Expired GB925538A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12966A US3192204A (en) 1960-03-07 1960-03-07 Trifluoromethylthiaxanthene and -xanthene derivatives
US2693960A 1960-05-05 1960-05-05

Publications (1)

Publication Number Publication Date
GB925538A true GB925538A (en) 1963-05-08

Family

ID=26684247

Family Applications (2)

Application Number Title Priority Date Filing Date
GB793161A Expired GB925538A (en) 1960-03-07 1961-03-03 Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives
GB1914062A Expired GB925539A (en) 1960-03-07 1961-03-03 Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1914062A Expired GB925539A (en) 1960-03-07 1961-03-03 Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives

Country Status (5)

Country Link
BE (1) BE600735A (en)
DE (2) DE1210890B (en)
FR (1) FR1002M (en)
GB (2) GB925538A (en)
SE (1) SE333573B (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157658A (en) * 1963-07-05 1964-11-17 Searle & Co 1-carbalkoxy-4-(9-xanthenyl) piperazines and related compounds
US3159636A (en) * 1963-07-05 1964-12-01 Searle & Co 1-amino-4-(xanthenyl and thioxanthenyl) piperazines
US5104858A (en) * 1988-09-29 1992-04-14 Yale University Sensitizing multidrug resistant cells to antitumor agents
WO2005037820A1 (en) * 2003-10-17 2005-04-28 Laboratorio Chimico Internazionale S.P.A. Process for the preparation of z-flupentixol
WO2005105145A1 (en) 2004-04-30 2005-11-10 Bkg Pharma Aps Treatment of infectious diseases
EP2301545A1 (en) 2007-01-05 2011-03-30 BKG Pharma ApS Thioxanthene derivatives for use in the treatment of infectious diseases
EP2374450A1 (en) 2010-04-06 2011-10-12 H. Lundbeck A/S Flupentixol compositions
CN104693173A (en) * 2015-03-09 2015-06-10 广东帅广医药有限公司 Preparation method of flupentixol hydrochloride
CN107987053A (en) * 2017-12-08 2018-05-04 重庆植恩药业有限公司 A kind of preparation method of high-purity Z-type Flupenthixol Hydrochloride

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196549A (en) * 1991-06-11 1993-03-23 E. I. Du Pont De Nemours And Company Polyethers based on 9,9-bis-perfluoroalkyl-3,6-dihydroxy-xanthene or 9-aryl-9-perfluoroalkyl-3,6-dihydroxy-xanthane

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1044103B (en) * 1956-06-12 1958-11-20 Hoffmann La Roche Process for the production of xanthene or thioxanthene derivatives
AT202152B (en) * 1956-12-28 1959-02-10 American Cyanamid Co Process for the preparation of new dimethylaminopropylidene thiaxanthenes.
AT202143B (en) * 1956-12-28 1959-02-10 American Cyanamid Co Process for the preparation of new dimethylaminopropylidenexanthenes
FR1173489A (en) * 1957-04-04 1959-02-25 Merck & Co Inc Substituted thiaxanthenes

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157658A (en) * 1963-07-05 1964-11-17 Searle & Co 1-carbalkoxy-4-(9-xanthenyl) piperazines and related compounds
US3159636A (en) * 1963-07-05 1964-12-01 Searle & Co 1-amino-4-(xanthenyl and thioxanthenyl) piperazines
US5104858A (en) * 1988-09-29 1992-04-14 Yale University Sensitizing multidrug resistant cells to antitumor agents
WO2005037820A1 (en) * 2003-10-17 2005-04-28 Laboratorio Chimico Internazionale S.P.A. Process for the preparation of z-flupentixol
WO2005105145A1 (en) 2004-04-30 2005-11-10 Bkg Pharma Aps Treatment of infectious diseases
EP2260870A2 (en) 2004-04-30 2010-12-15 BKG Pharma ApS Treatment of infectious diseases with combinations of a thioxanthene derivative with an anti-infective agent
EP2301545A1 (en) 2007-01-05 2011-03-30 BKG Pharma ApS Thioxanthene derivatives for use in the treatment of infectious diseases
EP2374450A1 (en) 2010-04-06 2011-10-12 H. Lundbeck A/S Flupentixol compositions
CN104693173A (en) * 2015-03-09 2015-06-10 广东帅广医药有限公司 Preparation method of flupentixol hydrochloride
CN107987053A (en) * 2017-12-08 2018-05-04 重庆植恩药业有限公司 A kind of preparation method of high-purity Z-type Flupenthixol Hydrochloride
CN107987053B (en) * 2017-12-08 2023-04-14 植恩生物技术股份有限公司 Preparation method of high-purity Z-type flupentixol hydrochloride

Also Published As

Publication number Publication date
BE600735A (en) 1961-08-28
DE1210890B (en) 1966-02-17
FR1002M (en) 1961-12-18
SE333573B (en) 1971-03-22
GB925539A (en) 1963-05-08
DE1518325B1 (en) 1970-08-27

Similar Documents

Publication Publication Date Title
GB925538A (en) Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives
GB932494A (en) Xanthenes and thiaxanthenes and method of producing the same
HUT39175A (en) Process for producing 7-/3-aryl-1-piperazinyl/- and 7-/3-cyclohexyl-1-piperazinyl/-3-quinoline-carboxylic acids and pharmaceutical compositions containing them as active agents
GB1023214A (en) Carbocyclic hydroxyamines
ES2060667T3 (en) ARALQUILAMINOALCOXIFENILO DERIVATIVES, PREPARATION PROCEDURE AND COMPOSITIONS CONTAINING THEM.
PE20040768A1 (en) ARILEN- (2-AMINO-PHENYL) -CARBOXAMIDE DERIVATIVES AS HISTONE DESACETILASE (HDAC) INHIBITORS
JPS552684A (en) *44phenyll22thiazolyl**oxaminic ester*its manufacture and drug containing it for asthma therapy
SE7408245L (en)
AR240815A2 (en) Aroyl benzofuran and benzothiophene acetic and propionic acids processes for their production and pharmaceutical compositions containing them
GB981046A (en) Hexahydro-4ah-8,9c-iminoethano phenanthro-[4,5-b,c,d]-furan derivatives
ES438138A1 (en) Thioxanthone carboxylic acids and derivatives
NO923824L (en) USE OF TRINITROBENZENES OR CARCAMIC ACID IN TREATMENT OF CANCER OR VIRUS DISEASES
ATE48993T1 (en) AETHEROXIDE DERIVATIVES OF CYCLOPROPYLPHENOLS.
ES414954A1 (en) Halogenated 4-(4&#39;-bisphenylyl)-butanols
ES381580A1 (en) Hexahydro-fluoren-2-yloxy alkanoic acids and esters thereof
ES435567A1 (en) Disubstituted xanthone carboxylic acid compounds
ES405648A1 (en) Procedure for the preparation of new acids 4- (4 bifenilil) -4-hydroxy-butirrics, its esteres or lactonas. (Machine-translation by Google Translate, not legally binding)
ES409089A1 (en) Benzodizepines
MX3366E (en) PROCEDURE FOR THE PREPARATION OF OMEGA ACIDS- (6,11-DIHIDRO-11-OXODIBENZ (B, E,) OXEPIN-2-IL) - ALKANOIC
GB923357A (en) Cinnamamide derivatives and process for their preparation
ES404786A1 (en) Xanthone carboxylic acids and derivatives
ES430320A1 (en) Amino acid ester
DK1144354T3 (en) Anhydride stabilization
ES382190A1 (en) Procedure for the preparation of new derivatives of tiepine and oxepine. (Machine-translation by Google Translate, not legally binding)
ES426948A1 (en) Procedure for the preparation of new 1,4-benzodiazepinas. (Machine-translation by Google Translate, not legally binding)